President and CEO
Ulthera, Division of Merz Pharma GmbH
After graduating from Kent State University, Matt spent time with J&J, Baxter International(23 years) and one failed start-up before achieving success as CEO of Ulthera, Inc., a medical device start-up company located in Mesa, AZ. Ulthera filed to go public in January, 2014, before being acquired by Merz Pharma, out of Frankfurt Germany in July, 2014, for $600M, representing 6.6X trailing twelve months sales. Benefiting from exposure to many positive business practices at J&J and Baxter and adjusting to the entrepreneurial environment of the failed start-up, enabled Matt to adopt “best practices” as the second Ulthera employee in July, 2006. With a “Servant Leader” management philosophy, he was able to establish a BHAG(Big, Hairy Audacious Goal), seven Operating Principles and a broader Purpose for the organization while attracting a top-notch management team.His two-year retention with Merz ends on June 30th, 2016.